Gelion lands £2 million Mitsui Kinzoku deal to advance sulfur batteries

What has Gelion announced?

Gelion PLC has signed a joint development agreement with Mitsui Kinzoku to validate its Nano-Encapsulated Sulfur, or NES™, cathode active material in high-energy-density sulfur batteries.

Cathode active material, usually shortened to CAM, is the material within a battery's cathode that stores and releases energy during charging and discharging.

The work will cover both liquid and solid-state sulfur battery cells. Gelion says the technology is being developed for potential requirements across automotive, stationary energy storage, consumer electronics, aerospace and defence markets.

Importantly for an early-stage battery technology company, this is a paid collaboration. Mitsui Kinzoku will pay Gelion £2 million through staged payments linked to project milestones.

The specific commercial terms, milestone schedule and expected project duration have not been disclosed.

The original company announcement also includes an option for Mitsui Kinzoku to negotiate manufacturing and distribution rights for NES™ CAM in certain Asian territories.

The key figures

Item	Detail
Development funding	£2 million
Payment structure	Staged payments linked to milestones
Battery formats	Liquid and solid-state sulfur cells
Potential future rights	Manufacturing and distribution in certain Asian territories
Mitsui Kinzoku market capitalisation	Approximately £8.4 billion at 6 August 2026
Detailed commercial terms	Not disclosed
Project timetable	Not disclosed

Why the £2 million matters

The most immediate benefit is straightforward: Gelion is being paid to carry out development work that supports its wider commercialisation strategy.

For a company developing new battery materials, moving from laboratory performance to repeatable industrial production can require significant spending. The £2 million does not remove Gelion's broader funding requirements, which were not addressed in this announcement, but it provides external support for part of the validation and scale-up programme.

The milestone structure also deserves attention. Gelion will not necessarily receive the full amount immediately. Payments will be made in stages as project milestones are reached, although the individual payment amounts and technical conditions are confidential.

That means investors should distinguish between the headline £2 million agreement value and cash already received. The latter was not disclosed.

Even so, funded development is generally more commercially meaningful than an unpaid memorandum of understanding. Mitsui Kinzoku is committing money to the programme, rather than simply expressing an interest in Gelion's technology.

Mitsui Kinzoku provides industrial validation

Mitsui Kinzoku is a Japan-based global supplier of metals and engineered materials, with operations spanning functional materials, metals and automotive parts. Gelion describes it as a leading advanced battery materials business and a Tier-1 manufacturer.

The company was valued at approximately £8.4 billion on 6 August 2026. Its scale does not guarantee that Gelion's technology will reach commercial production, but it gives the collaboration industrial weight.

Gelion's challenge is not only to demonstrate that NES™ works inside sulfur battery cells. It must also show that the material can be manufactured consistently, at industrial volumes and at an acceptable cost.

Management believes Mitsui Kinzoku could help establish NES™ production facilities and, if development proceeds successfully, support full-scale commercial supply.

That builds on Gelion's existing partnership strategy. The company already has collaborations with TDK, QinetiQ, Nissan, the US National Laboratory of the Rockies and Germany's Max Planck Institute of Colloids and Interfaces. Investors can read more about the earlier Gelion and TDK sulfur battery collaboration.

What makes NES™ potentially useful?

Gelion is trying to replace the critical minerals used in conventional lithium-ion battery cathodes with sulfur.

Its proprietary NES™ material encapsulates sulfur at the nanoscale. Gelion says this approach is designed to offer higher energy density while remaining compatible with existing battery manufacturing infrastructure.

Sulfur is abundantly available and, according to the company, free from the supply chain constraints affecting conventional critical-mineral cathodes. Compatibility with existing production lines could also matter commercially because customers may not need entirely new manufacturing systems to adopt the material.

Those are the intended advantages. This agreement is part of the process of validating whether Gelion can deliver them in practical liquid and solid-state cells, before progressing towards commercial-scale material production.

The Asian manufacturing option needs perspective

The agreement creates a possible route to manufacturing and distribution in Asia, but it is not yet a manufacturing licence or supply contract.

Mitsui Kinzoku has an option to negotiate rights for certain Asian territories. The territories, economics and other licensing conditions have not been disclosed, and the final terms still need to be negotiated.

Investors should therefore treat this as a pathway rather than a completed commercial outcome.

If the technical programme succeeds and both parties agree acceptable terms, Gelion could gain access to an experienced industrial partner capable of helping scale production and reach customers. If those negotiations do not result in a binding deal, however, the option itself may not produce manufacturing income.

No minimum production volumes, licence fees, royalties, commercial orders or revenue forecasts were announced.

Positives and risks for Gelion shareholders

The announcement has several clear positives:

• Gelion will receive up to £2 million through a funded development programme.
• A large battery materials group is committing resources to validate NES™.
• The work covers both liquid and solid-state sulfur battery architectures.
• The agreement supports Gelion's move from technical validation towards industrial scale-up.
• There is a potential route to Asian manufacturing and distribution rights.
• Mitsui Kinzoku may strengthen Gelion's engagement with original equipment manufacturers, or OEMs, across several target markets.

There are also important limitations:

• NES™ remains an early-stage technology with technical and scale-up risk.
• Payments depend on milestones that have not been disclosed.
• The timetable for receiving the full £2 million is not disclosed.
• Future manufacturing and distribution rights are only subject to negotiation.
• No commercial supply orders, production volumes or recurring revenues were announced.
• Much of the agreement remains confidential, limiting investors' ability to assess its economics.

What investors should watch next

The most useful future updates would include successful technical milestones, receipt of staged payments and evidence that NES™ can be produced consistently at larger volumes.

Progress towards Gelion's planned pilot-scale US CAM facility could also be relevant. Management says the Mitsui Kinzoku programme aligns with its work under a Cooperative Research and Development Agreement with the Department of Energy's National Laboratory of the Rockies.

Beyond technical validation, the major commercial milestone would be a binding manufacturing or distribution agreement containing clearer information on territories, capacity, licence economics or supply commitments.

For now, the £2 million funding and involvement of an established battery materials manufacturer represent tangible progress. The announcement strengthens Gelion's industrial validation story, but the larger prize - dependable commercial-scale production and sales - still depends on successful development and future negotiations.